Murray Stewart
Directeur/Bestuurslid bij X4 PHARMACEUTICALS, INC.
Vermogen: 193 419 $ op 31-05-2024
Actieve functies van Murray Stewart
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| X4 PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 29-03-2019 | - |
| Hoofd Techniek/Wetenschap/O&O | 29-11-2022 | 01-08-2023 | |
| Vivli Center For Global Clinical Research Data | Directeur/Bestuurslid | - | - |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Directeur/Bestuurslid | - | - |
Loopbaan van Murray Stewart
Eerdere bekende functies van Murray Stewart
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VECTIVBIO HOLDING AG | Directeur/Bestuurslid | 02-09-2021 | 26-06-2023 |
| Independent Dir/Board Member | 02-09-2021 | 26-06-2023 | |
| AMARIN CORPORATION PLC | Directeur/Bestuurslid | 10-01-2023 | 06-03-2023 |
| Independent Dir/Board Member | 10-01-2023 | 06-03-2023 | |
| RHYTHM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-10-2018 | 10-09-2021 |
| NOVELION THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 27-11-2017 | 17-10-2018 |
| GSK PLC | Hoofd Techniek/Wetenschap/O&O | 01-04-2014 | 01-11-2017 |
| Corporate Officer/Principal | - | - |
Opleiding van Murray Stewart
| The University of Southampton | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 3 |
Operationeel
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
| Vivli Center For Global Clinical Research Data | |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Beurs
- Insiders
- Murray Stewart
- Ervaring
